Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Reducing Hospital Stays for Patients Discharged to Nursing Homes: An Evolving Program
Link ID 5497
Title Reducing Hospital Stays for Patients Discharged to Nursing Homes: An Evolving Program
Url http://www.medscape.com/viewarticle/572831?src=rss
Description Unless innovations in care for difficult-to-place patients are developed, these patients are likely to congregate in acute hospitals and compromise the ability of these facilities to provide care.
Topics in Advanced Practice Nursing eJournal
Category Articles > Business of Medicine
Keywords
Date May 9, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Business of Medicine
1. Responsible Surgical Innovation: Natural Orifice Transluminal Endoscopic Surgery (NOTES)
  NOTES: A model for systematic evaluation of new procedures
AccessMedicine from McGraw-Hill
Category:   Articles > Business of Medicine


2. Brain-Boosting Drugs Spark Ethical Debate in UK
  A rise in healthy people popping pills to boost performance in exams or work, raises long-term ethical and safety concerns about the effects of such treatments, British doctors said on Thursday. Reuters Health Information
Category:   Articles > Business of Medicine


3. Class 1 Recall for Cordis Fire Star, Dura Star Balloon Catheters
  Cordis is recalling certain lots of its recently introduced Fire Star RX and Dura Star RX coronary balloon catheters due to a risk of slow or low deflation. Medscape Medical News
Category:   Articles > Business of Medicine


4. U.S. FDA Warns Philips Medical Over Procedures
  U.S. health regulators have warned Philips Medical Systems Inc about a host of problems with its manufacturing procedures at an Ohio plant, including a failure to oversee proper device design, according to a letter released on Tuesday. Reuters Health Information
Category:   Articles > Business of Medicine


5. Why the NIH Trial to Assess Chelation Therapy (TACT) Should Be Abandoned
  The $30 million, NIH Phase 3 Trial to Assess Chelation Therapy (TACT) exposes subjects to a risky method that is known to be ineffective. The TACT should be abandoned and its origins investigated.
The Medscape Journal of Medicine
Category:   Articles > Business of Medicine




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS